Ipamorelin — research catalogue reference

Ipamorelin is a synthetic pentapeptide that acts at the ghrelin/growth hormone secretagogue receptor. It is described in the literature as more selective than earlier secretagogues such as GHRP-6 and GHRP-2.

It is listed as a laboratory reference material for in-vitro research only and is not offered for human or veterinary use. A research-use label does not by itself determine regulatory status; see the compliance page for official TGA guidance.

Research protocols often pair a GHRH analogue such as CJC-1295 with a secretagogue such as Ipamorelin because the two act at different receptors. Comparative and combination studies are common in the published pharmacology literature.

We make no claims about combined effects. The pairing is described here only because it is how the compounds appear in the research record.

Aussie Peptides does not publish product- or lot-specific preparation, storage or stability data. Base preparation, storage and disposal on the supplier safety data sheet (SDS) and your institution's standard operating procedures.

Where a vial label shows a lot number and a batch report has been published for that lot, it can be looked up on the verify page and recorded alongside your experimental data.

Materials on this site are supplied strictly for in-vitro laboratory research. They are not offered for human or veterinary use. A research-use label does not by itself determine regulatory status; see the compliance page for official TGA guidance.

Purchasers must be 18 or over and are responsible for handling, storing and disposing of research materials in line with their institution's requirements and applicable Australian law.

Nothing on this page is medical advice, a dosing protocol, or a claim of therapeutic benefit. It summarises what the published research literature investigates.